Electrocardiographic alterations in patients consuming synthetic cannabinoids
| Autor: | Hayriye Mihrimah Ozturk, Mikail Yarlioglues, Yakup Alsancak, Mehmet Ozgur Erdogan, Sani Namik Murat, Mustafa Duran, M Hamid Boztas, Selcuk Ozturk |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty 030204 cardiovascular system & hematology 03 medical and health sciences Electrocardiography Young Adult 0302 clinical medicine Heart Conduction System Heart Rate Internal medicine Synthetic cannabinoids Heart rate Medicine Humans Pharmacology (medical) In patient cardiovascular diseases 030212 general & internal medicine Pharmacology medicine.diagnostic_test business.industry Cannabinoids Arrhythmias Cardiac Psychiatry and Mental health Anesthesia Cardiology Female Electrical conduction system of the heart business medicine.drug |
| Zdroj: | Journal of psychopharmacology (Oxford, England). 32(3) |
| ISSN: | 1461-7285 |
| Popis: | The aim of this study was to investigate the electrocardiographic parameters in patients consuming synthetic cannabinoids.Thirty-five patients who were consuming synthetic cannabinoids were enrolled to the study, prospectively. The control group included 35 healthy age and sex-matched volunteers. The standard 12-lead surface electrocardiograms of the study population were recorded. P maximum (PPAltered electrocardiography parameters linked with atrial and ventricular arrhythmia development may be observed in patients consuming synthetic cannabinoids. These patients should be evaluated regularly for cardiovascular disease and arrhythmia development. The electrocardiogram, which is a cheap and easy test to apply, can be used to determine the pro-arrythmic risk in patients consuming synthetic cannabinoids. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|